2024

  • Luo Z, Zhuang K, Kim SJ, Vollett KDW, Lou Z, Wang J, Cheng HYM, Khazaei M, Fehlings MG, Cheng HM. “Longitudinal MRI tracking of transplanted neural progenitor cells in the spinal cord utilizing the bright ferritin mechanism,” Stem Cells Translational Medicine 2024 (in press).

  • Troy AM, Normukhamedova D, Grothe D, Momen A, Zhou YQ, McFadden M, Hussain M, Billia F, Cheng HM. “Impact of ovary-intact menopause in a mouse model of heart failure with preserved ejection fraction,” American Journal of Physiology – Heart and Circulatory Physiology 326(3), H522-H537, 2024.

2023

  • Zhuang K, Romagnuolo R, Sadikov Valdman T, Vollett KDW, Szulc DA, Cheng HYM, Laflamme MA, Cheng HM. “Bright ferritin for long-term MR imaging of human embryonic stem cells,” Stem Cell Research & Therapy 14, 330, 2023.

  • Loai S, Qiang B, Laflamme MA, Cheng HM. “Blood-pool MRI assessment of myocardial microvascular reactivity,” Frontiers in Cardiovascular Medicine 10, 1216587, 2023.

  • Curtis AD, Mertens AJ, Cheng HM. “A predictive signal model for dynamic cardiac magnetic resonance imaging,” Scientific Reports 13(1), 10296, 2023.

  • Cheng HM. “A primer on in vivo cell tracking using MRI,” Frontiers in Medicine 10, 1193459, 2023.

  • Vollett KDW, Szulc DA, Cheng HM. “A manganese porphyrin platform for the design and synthesis of molecular and targeted MRI contrast agents,” International Journal of Molecular Sciences 24(11), 9532, 2023.

  • Tawagi E, Ung T, Cheng HM, Santerre JP. “Arrhenius-model-based degradable oligourethane hydrogels for controlled growth factor release,” Acta Biomaterialia 166, 167-186, 2023.

  • Tawagi E, Vollett KDW, Szulc DA, Santerre JP, Cheng HM. “In vivo MRI tracking of degradable polyurethane hydrogel degradation in situ using a manganese porphyrin contrast agent,” Journal of Magnetic Resonance Imaging 58, 1139-1150, 2023.

  • Hong GQ, Wei YT, Morley WAW, Wan M, Mertens AJ, Su Y, Cheng HM. “Dual-domain accelerated MRI reconstruction using transformers with learning-based undersampling,” Computerized Medical Imaging and Graphics 106, 102206, 2023.

2022

  • Cheng HM. “Emerging MRI techniques for molecular and functional phenotyping of the diseased heart,” Frontiers in Cardiovascular Medicine 9, 1072828, 2022.

  • Loai S, Szulc DA, Cheng HM. “3D bioprinted MR-trackable regenerative scaffold for post-implantation monitoring on T1-weighted MRI,” Journal of Magnetic Resonance Imaging 56(2), 570-578, 2022.

  • Loai S, Sun X, Husain M, Laflamme MA, Yeger H, Vasconcelos SS, Cheng HM. “Microvascular dysfunction in skeletal muscle precedes myocardial vascular changes in diabetic cardiomyopathy: sex-dependent differences,” Frontiers in Cardiovascular Medicine 9, 886687, 2022.

  • Hegazi S, Cheng AH, Krupp JJ, Tasaki T, Liu J, Szulc DA, Ling HH, Garcia JR, Seecharran S, Basiri T, Amiri M, Anwar Z, Ahmad S, Nayal K, Sonenberg N, Liu BH, Cheng HLM, Levine JD, Cheng HYM. “UBR4/POE facilitates secretory trafficking to maintain circadian clock synchrony,” Nature Communications 13(1), 1594, 2022.

  • Curtis AD, Cheng HM. “Primer and historical review on rapid cardiac CINE MRI,” Journal of Magnetic Resonance Imaging 55(2), 373-388, 2022.

2021

  • Troy AM, Cheng HM. “Microvascular reactivity: a review of vasomodulating stimuli and non-invasive imaging assessment,” Physiological Measurement 42(9), 1-25, 2021.

  • Loai S, Zhou YQ, Vollett KDW, Cheng HM. “Skeletal muscle microvascular dysfunction manifests early in diabetic cardiomyopathy,” Frontiers in Cardiovascular Medicine 8, 715400, 2021.

  • Mokhtari RB, Qorri B, Baluch N, Sparaneo A, Fabrizio FP, Muscarella LA, Tyker A, Kumar S, Cheng HM, Szewczuk MR, Das B, Yeger H. “Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling PI3K/Akt/mTOR survival pathway and inducing apoptosis,” Oncotarget 12(15), 1470-1489, 2021.

  • Mokhtari RB, Sambi M, Qorri B, Baluch N, Ashayeri N, Kumar S, Cheng HM, Yeger H, Das B, Szewczuk MR. “The next-generation of combination cancer immunotherapy: epigenetic immunomodulators transmogrify immune training to enhance immunotherapy,” Cancers 13(14), 3596, 2021.

  • Mokhtari RB, Qorri B, Sambi M, Baluch N, Kumar S, Das B, Szewczuk MR, Yeger H, Cheng HM. “3D multicellular stem-like human breast tumor spheroids enhance tumorigenicity of orthotopic xenografts in athymic nude rat model,” Cancers 13(11), 2784, 2021.

For Complete list please visit: http://www.ncbi.nlm.nih.gov/pubmed/?term=hai-ling+Cheng